NCT07838610

Brief Summary

Participants will be divided into two groups, with both receiving conventional physical therapy along with their respective thoracic intervention. One group will receive thoracic manipulation at the identified T1-T7 segment using a controlled High-Velocity, Low-Amplitude thrust in the prone position at the end of full exhalation, while the other group will receive central PosterioAnterior thoracic mobilization in the prone position for 30 repetitions with a 1-minute rest between two sets. The most painful or stiffest segment will be identified using the Passive Accessory Intervertebral Movement (PAIVM) test; if no joint sign is present, mobilization will be performed at T6-T7.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Feb 2026Jan 2027

Study Start

First participant enrolled

February 12, 2026

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 24, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2027

Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

10 months

First QC Date

September 18, 2026

Last Update Submit

September 18, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Shoulder Pain Intensity

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 to 10, where 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, and 7-10 = severe pain.

    Baseline and after 4 weeks of intervention

  • Shoulder range of motion

    Shoulder range of motion will be measured using a universal goniometer. Shoulder flexion, abduction, internal rotation, and external rotation will be assessed and recorded in degrees.

    Baseline and after 4 weeks of intervention.

  • Functional disability

    Functional disability will be assessed using the Shoulder Pain and Disability Index (SPADI), consisting of 13 items assessing shoulder pain and functional limitations. with 5 items assessing pain and 8 items evaluating functional limitations. Each item is scored ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult required help).

    Baseline and after 4 weeks of intervention

Study Arms (2)

Group A:Thoracic manipulation with standard physical therapy

EXPERIMENTAL

The intervention will be conducted over 4 weeks, with 3 sessions per week. The treatment protocol will include stretching, strengthening with manual resistance, glenohumeral mobilization, and thoracic manipulation (HVLA).

Procedure: Thoracic Manipulation

Group B:Thoracic Mobilization with standard physical therapy

EXPERIMENTAL

The intervention will be conducted over 4 weeks, with 3 sessions per week. The treatment protocol will include stretching, strengthening with manual resistance, glenohumeral mobilization, and thoracic mobilization.

Procedure: Thoracic mobilization

Interventions

Group A will receive thoracic thrust manipulation in addition to the conventional treatment program. The target thoracic segment (T1-T7) will be identified through posterior-to-anterior (PA) assessment. With the patient in a prone position, the therapist will position and preload the tissues at the identified segment and deliver a quick, controlled, high-velocity, low-amplitude (HVLA) thrust at the end of the patient's full expiration.

Group A:Thoracic manipulation with standard physical therapy

Thoracic mobilization will be performed as an adjunct to the conventional physical therapy program. Central posterior-to-anterior oscillatory mobilization will be performed in the prone position. The treatment segment will be identified using the Passive Accessory Intervertebral Motion (PAIVM) test, with the most painful or stiffest segment selected; if no joint sign is present, mobilization will be applied at T6-T7.

Group B:Thoracic Mobilization with standard physical therapy

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age range between 40 and 60 years.
  • Both male and female patients with unilateral or bilateral shoulder pain.
  • Pain persisting for at least 3 months.
  • Decreased shoulder ROM, including external rotation, abduction, internal rotation, and flexion, with both active and passive ROM reduced by more than 50%.
  • Clinically diagnosed with Stage 2 or Stage 3 adhesive capsulitis.

You may not qualify if:

  • History of fracture, surgery, or dislocation in the affected shoulder.
  • Shoulder pain resulting from systemic diseases such as rheumatoid arthritis, infection, or tumors, or conditions such as myelopathy (positive Hoffman's sign).
  • Neurological conditions such as stroke or cervical radiculopathy (positive Spurling's test).
  • Thoracic Outlet Syndrome (positive Roos test).
  • Uncontrolled hypertension or cardiac instability, including unstable angina, recent myocardial infarction, or other cardiovascular conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University College of Physical Therapy

Islamabad, Punjab Province, 44000, Pakistan

RECRUITING

MeSH Terms

Conditions

Bursitis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Central Study Contacts

Marwa Asim, MS-OMPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2026

First Posted

September 24, 2026

Study Start

February 12, 2026

Primary Completion (Estimated)

December 18, 2026

Study Completion (Estimated)

January 18, 2027

Last Updated

September 24, 2026

Record last verified: 2026-09

Locations